| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |